Related Experiment Video
Updated: Dec 24, 2025

A Cell Culture Model of Resistance Arteries
Published on: September 8, 2017
Involvement of Heparanase in Endothelial Cell-Cardiomyocyte Crosstalk
Rui Shang1, Nathaniel Lal1, Karanjit Puri1
1Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada.
Insights
Diabetes management often overlooks cardiac fuel utilization. In diabetic hearts, uncontrolled fat use disrupts energy metabolism, leading to heart failure. Understanding the heparanase-LPL-VEGFs network is key to preventing cardiac damage.
Area of Science:
- Cardiovascular Metabolism
- Diabetic Cardiomyopathy
- Molecular Cardiology
Background:
- Diabetes management traditionally focuses on blood glucose control, often neglecting cardiac metabolic changes.
- Diabetic hearts alter fuel utilization, shifting from glucose and fats to predominantly fats for energy.
- This metabolic shift, if uncontrolled, leads to toxic byproducts, impairing heart function and causing heart disease.
Purpose of the Study:
- To investigate the role of the heparanase-LPL-VEGFs network in regulating cardiac fat metabolism in diabetes.
- To understand how the dysfunction of this network contributes to diabetic cardiomyopathy.
- To identify potential therapeutic targets for mitigating diabetes-related cardiac damage.
Main Methods:
- Analysis of fuel utilization in diabetic heart models.
- Investigation of the heparanase-LPL-VEGFs complex interactions.
- Assessment of fat supply and breakdown pathways in the diabetic heart.
Main Results:
- The diabetic heart exhibits a shift towards fat utilization for energy.
- Dysregulation of the heparanase-LPL-VEGFs network leads to fat oversupply and cellular damage.
- Uncontrolled fat metabolism generates toxic byproducts, weakening cardiac function.
Conclusions:
- The heparanase-LPL-VEGFs ensemble plays a critical role in cardiac fat metabolism.
- Disruption of this network in diabetes results in detrimental metabolic changes and cardiac damage.
- Targeting the heparanase-LPL-VEGFs network may offer a strategy to restore metabolic balance and protect the diabetic heart.
Abstract:
Traditionally, the management of diabetes has focused mainly on controlling high blood glucose levels. Unfortunately, despite valiant efforts to normalize this blood glucose, poor medication management predisposes these patients to heart failure. Following diabetes, how the heart utilizes different sources of fuel for energy is key to the development of heart failure. The diabetic heart switches from using both glucose and fats, to predominately using fats as an energy resource for maintaining its activities. This transformation to using fats as an exclusive source of energy is helpful in the initial stages of the disease and is tightly controlled. However, over the progression of diabetes, there is a loss of this controlled supply and use of fats, which ultimately has terrible consequences since the uncontrolled use of fats produces toxic by-products which weaken heart function and cause heart disease. Heparanase is a key player that directs how much fats are provided to the heart and does so in association with several partners like LPL and VEGFs. Together, they regulate the amount of fats supplied, and their subsequent breakdown to provide energy. Following diabetes, there is a disruption in this network resulting in fat oversupply and cell death. Understanding how the heparanase-LPL-VEGFs "ensemble" cooperates, and its dysfunction in the diabetic heart would be useful in restoring metabolic equilibrium and limiting diabetes-related cardiac damage.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Overview of Cell-Matrix Interactions
Mechanism of Angiogenesis
Paracrine Signaling
Intracellular Signaling Affects Focal Adhesions
Some...

